tbuckley/cabot-search huggingface dataset:
Passive Containment and Reverse Remodeling by a Novel Textile Cardiac Support Device
Authors: Wolfgang F. Konertz, J. Edward Shapland, Holger Hotz, Simon Dushe, Jan Peter Braun, Katrin Stantke, Franz Xaver Kleber
Journal: Circulation (2001)

Background Progressive remodeling and dilation of cardiac chambers is responsible in part for myocardial dysfunction in chronic heart failure. Preclinical studies with suitable animal models indicate that a passive cardiac constraint device can promote reverse remodeling, with improvement in cardiac function. We hypothesize that such a device could provide benefit for stable heart failure patients in New York Heart Association (NYHA) class II and III . Methods and Results From April 1999 to March 2000, 27 patients received Acorn’s Cardiac Support Device (CSD) during an initial safety/feasibility study. In 11 patients, the only surgical measure was CSD placement. Most patients suffered from idiopathic cardiomyopathy; 4 were in NYHA class II, one was in class II/III, and 6 were in class III. All were stable on intensive medical treatment. The CSD, a textile polyester device, was fitted snugly around the heart during surgery. All patients survived surgery and recovered smoothly. Three months after surgery, 56% of patients were in NYHA class I, 33% were in class II, and 11% were in class II/III. Echocardiography showed an improvement in left ventricular ejection fraction from an average of 22% to 28% and 33% at 3 and 6 months, respectively. Simultaneously, the left ventricular end-diastolic dimension decreased from 74 mm to 68 mm and 65 mm, respectively. Mitral valve regurgitation (on a scale of 0 to 4+) decreased from 1.3 to 0.7 by 3 months. Quality-of-life indices correlated with the apparent reversal of ventricular remodeling. Preoperative cardiac medications remained virtually unchanged after implant. Conclusions In the short- and intermediate-term, CSD implantation seems to ameliorate symptoms and improve cardiac and functional performance in heart failure patients. Worldwide randomized trials are currently underway.
The Cholera
Journal: BMJ (1893)

JULY however, also yieMded negative results.This is not surpris- ing considering the age of the sample, even should the comma bacilli have been originally present in it.This in previous experiments 1 which I have made with Koch's comma bacilli I was able to demonstrate their presence in sterilised Thames and deep well water after nine days, and in sterilised London sewage after eleven months, but in unsterilised waters Kraus.Karlinski, and Gartner were unable to discover them after three days.It is quite possible, therefore, that they might have been present, and have disappeared before my examination was made.Results of analysis expressed in parts per 100,000 of a sample of Hamburg water supply sent by Mr. Ernest Hart, and
The Resource-Based Relative Value Scale
Authors: M. L. Janower
Journal: JAMA (1988)

<h3>In Reply.</h3> —Dr Janower has expressed views on several aspects of the Resource-Based Relative Value Scale that are incorrect or that indicate misunderstanding of the design of the project. Most important, the intensity of a procedure or service cannot only be measured, but can be measured quite accurately. Unlike measurement of time, practice costs, and the opportunity costs of training, intensity cannot be measured by objective means. Subjective assessments are, however, neither unscientific nor arbitrary. During the past 25 years, measurement psychologists have developed methods and demonstrated that one can obtain, using subjective judgments, reproducible and valid measurements of previously unquantified matters when assessments are obtained in carefully designed studies.<sup>1</sup> With the aid of experts in the field of measurement psychology, we have designed studies, using the method of magnitude estimation, of the relative work of physicians' services and have subjected this methodology to extensive validation trials. The methods
THE YOUNG PHYSICIAN AND MEDICAL DISCOVERY.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
"CHRISTIAN SCIENCE" AND MICHIGAN LAW.
Journal: JAMA (1899)

The following are the chief points of an opinion of Attorney-General Oren of Michigan, given in reply to a question as to the legal status of "Christian Science" healers and their duty as regards reporting of dangerous communicable diseases under the Michigan law. The act as amended requires reports to the health officer, and in its penal clause declares that every physician and person acting as a physician, who shall refuse or neglect to immediately give such notice shall forfeit for each such offense a sum not less than $10 nor more than $50. "It is plain," says the attorney-general, "from the wording of the above section of the act, that it applies to either physicians as such, or persons acting as physicians." The question whether a "Christian Science" healer is thus included is taken up, and he finds that the term "physician" is only applicable to one lawfully certified
Use of automated external defibrillator by first responders in out of hospital cardiac arrest: prospective controlled trial
Journal: BMJ (2004)

Notwithstanding some pessimistic views about the effects of biofeedback interventions for gastrointestinal conditions, w6 biofeedback training seems to be a good treatment for lower gastrointestinal disturbances, especially for pelvic floor dyssynergia.The effects of such training may not be limited to the anorectum and might also be useful in other conditions in which pelvic floor dyssynergia plays a role.w7 However, good quality research in this subject is lacking.Validated scoring systems and quantitative tests are still needed, as well as more uniform and strict criteria for pelvic floor dyssynergia. 1For good quality studies, we also need improved experimental designs, larger numbers of participants, clearly defined outcome measures, knowledge of the best treatment protocol, and long term follow up. 12Finally, it remains to be established whether other promising treatments for pelvic floor dyssynergia, whether used alone 25 or in combination with biofeedback, w8 could provide better clinical outcomes.
SALE OF MEDICINES IN ORIGINAL PACKAGES.
Journal: JAMA (1895)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Does breathing other people's tobacco smoke cause lung cancer?
Authors: P. R J Burch
Journal: BMJ (1986)

<h3>Educational aims</h3> To help readers understand the best way to use oxygen when they care for patients with medical emergencies. To encourage best practice in the use of emergency oxygen therapy. To raise awareness of the British Thoracic Society (BTS) guideline for emergency oxygen use. <h3>Summary</h3> Oxygen is the most commonly used drug in emergency medicine and when used judiciously in the treatment of hypoxaemia it undoubtedly saves life. However, oxygen is often used inappropriately and the dangers of over-oxygenation are unappreciated. In 2008, the first formal guidance on emergency oxygen use was produced by the British Thoracic Society. The guideline is objective, evidence based and peer reviewed, advocating safe use of oxygen by encouraging target saturation levels to be prescribed for each patient, based on a combination of what is believed to be safe and normal or near-normal. In the majority of patients a target saturation range of 94–98% is advised. The importance of recognition of patients at risk of type 2 respiratory failure is highlighted and, in such patients, a target saturation range of 88–92% is recommended.
Insulin Antibodies
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Stiff-man syndrome and clonazepam
Authors: U. Westblom
Journal: JAMA (1977)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
DR. FRANK P. FOSTER.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
CO2-Impermeable Plastic Bags for Artificial Cultivation of Tubercle Bacilli
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Epidemiological evolution of viral hepatitis in uremic patients in Taiwan - the Formosa like group
Authors: Yu-Ju Wei, Jia-Jung Lee, Chung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, Szu-Chia Chen, Sheng-Wen Niu, Lii-Jia Yang, Chia-Yen Dai, Jee-Fu Huang, Shang-Jyh Hwang, Wan-Long Chuang, Yi Wen Chiu, Ming-Lung Yu
Journal: Journal of Hepatology (2020)
Abstract 3545: High expression of miR-30a is associated with favorable breast cancer survival
Authors: Yuki Obata, Dionyssios Katsaros, Nicoletta Biglia, Yi Shen, Yuanyuan Fu, Zhanwei Wang, Herbert Yu
Journal: Cancer Research (2019)

Abstract Introduction: MicroRNAs (miRNAs) are single-stranded, small non-coding RNAs, consisting of about 20 nucleotides and studies have shown that miRNAs may play important roles in the development and progression of cancer. Members of the miR-30 family, including miR-30a, are reported to play different roles as oncogenes or tumor suppressor genes depending on the type of cancer in several studies. We studied miR-30a expression in breast cancer in relation to disease features and patient survival. Methods: We measured miR-30a expression in tumor samples of 509 breast cancer patients by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). Using the study-specific tertile distribution as cut-off, miR-30a expression data were grouped into low, medium, and high three categories. Hazards ratios (HRs) and 95% confidence intervals (CIs) were calculated to assess the association between miR-30a expression and breast cancer survival using the Cox proportional hazards regression model, and the analysis was adjusted for age at surgery, tumor grade, disease stage, and hormone receptor status. Overall survival (OS) was defined as the time interval from the date of surgery to the date of death or last follow-up. Disease-free survival (DFS) was the time interval from surgery to recurrence or last follow-up. We also retrieved breast cancer provisional data in The Cancer Genome Atlas (TCGA) using the web-based tool cBioPortal (http://www.cbioportal.org/index.do) and analyzed the association between miR-30a and breast cancer survival. Results: Patients with estrogen receptor (ER)-positive tumors had higher expression of miR-30a compared to those with ER-negative tumors (p = 0.0080). Patients with progesterone receptor (PR)-positive tumors also had higher miR-30a expression than those with PR-negative tumors (p = 0.0038). Survival analysis showed that patients with high expression of miR-30a had 58% reduction in risk of relapse (HR = 0.42, 95% CI = 0.21-0.83, p = 0.013) compared to those with low expression. This association remained significant (HR = 0.43, 95% CI = 0.21-0.89, p = 0.023) after adjustment for age at surgery, disease stage, tumor grade, and hormone receptor status. A significant association between miR-30a and overall survival was also observed in the TCGA data (HR = 0.60, 95% CI = 0.41-0.88, p = 0.0088). Conclusions: Our results suggest that high expression of miR-30a may reduce the risk of breast cancer relapse and miR-30a may act as a tumor suppressor in breast cancer. Citation Format: Yuki Obata, Dionyssios Katsaros, Nicoletta Biglia, Yi Shen, Yuanyuan Fu, Zhanwei Wang, Herbert Yu. High expression of miR-30a is associated with favorable breast cancer survival [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 3545.
An Introduction to the Study of Diseases of the Skin.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
New background for neurosis
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Erratum: Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice
Authors: V. Compernolle, K. Brusselmans, T. Acker, P. Hoet, M. Tjwa, H. Beck, S. Plaisance, Y. Dor, E. Keshet, F. Lupu, B. Nemery, M. Dewerchin, P. Van Veldhoven, K. Plate, L. Moons, D. Collen, P. Carmeliet
Journal: Nature Medicine (2002)
Retracted: Multifunctional Polymeric Nanosystems for Dual‐Targeted Combinatorial Chemo/Antiangiogenesis Therapy of Tumors
Authors: Fatima Zohra Dahmani, Yan Xiao, Juan Zhang, Yao Yu, Jianping Zhou, Jing Yao
Journal: Advanced Healthcare Materials (2021)

Adv. Healthcare Mater. 2016, 5, 1447–1461 DOI: 10.1002/adhm.201600169 In the original version of this paper, there were mistakes in Figure 6C and Figure S5B due to errors during the compilation of the images. For the data of HE staining, the images from group d was wrongly placed in the image position of group b and c in the process of combining images. In Figure S5B, the 1.3 cm image (saline group) was wrongly placed in the position of 3 cm during the process of re-organizing the data and compiling this figure for publication. The correct figures are shown below. These mistakes do not affect the results, discussions and conclusions published in this work, and the authors apologize for any confusion caused.